Literature DB >> 1752347

Age, sex and ICA influence on beta-cell secretion during the first year after the diagnosis of type 1 diabetes mellitus.

E Montaña1, M Fernandez-Castañer, P Rosel, J Gomez, J Soler.   

Abstract

We studied the independent influence of sex, age and islet-cell antibodies (ICA) on residual beta-cell secretion and metabolic control during the first year after the diagnosis of type 1 diabetes mellitus in 40 consecutive newly diagnosed patients. Glucagon-stimulated C-peptide secretion was measured after 5-10 days and 3, 6 and 12 months of diagnosis. ICA (JDF units) and complement-fixing ICA (CF-ICA) were determined at diagnosis and after 12 months. The influence of sex, age and ICA was analyzed in a multivariate analysis of variance of 3 factors (age, sex and ICA) for repeated measures over time. ICA and CF-ICA were positive in 75.0% and 35.0% of patients at diagnosis and in 48.7% and 20.5% of patients one year later. Persistence of ICA positivity was higher in females (p. less than 0.001) and in CF-ICA+ patients (p less than 0.01), but did not involve a different evolution of C-peptide secretion. Males had a lower C-peptide secretion than females (p = 0.023) during the first year after the diagnosis of type 1 diabetes, independently of the age and ICA status of the patients. Adult patients (greater than or equal to 18 years-old) had lower HbA1 values than younger patients (p = 0.006) and ICA+ patients with a moderate or high value (greater than 10 JDF units) had a lower C-peptide secretion over time (p = 0.031 at 6 months, p = 0.067 at 12 months) and higher HbA1 values (p = 0.056) than younger patients. HbA1 was significantly explained by ICA and C-peptide values in a stepwise multiple regression analysis (p = 0.005).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1752347

Source DB:  PubMed          Journal:  Diabete Metab        ISSN: 0338-1684


  3 in total

1.  Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study.

Authors:  D Dabelea; E J Mayer-Davis; J S Andrews; L M Dolan; C Pihoker; R F Hamman; C Greenbaum; S Marcovina; W Fujimoto; B Linder; G Imperatore; R D'Agostino
Journal:  Diabetologia       Date:  2012-09-20       Impact factor: 10.122

2.  Randomised prospective study for the effect of therapy on residual beta cell function in type-1 diabetes mellitus [ISRCTN70703138].

Authors:  Thomas Linn; Marion Mann; Markus Mann; Reinhard G Bretzel; Rolf H Boedeker
Journal:  BMC Endocr Disord       Date:  2003-12-10       Impact factor: 2.763

3.  Preservation of beta-cell function in autoantibody-positive youth with diabetes.

Authors:  Carla J Greenbaum; Andrea M Anderson; Lawrence M Dolan; Elizabeth J Mayer-Davis; Dana Dabelea; Giuseppina Imperatore; Santica Marcovina; Catherine Pihoker
Journal:  Diabetes Care       Date:  2009-07-08       Impact factor: 17.152

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.